...
首页> 外文期刊>The New Microbiologica >Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia
【24h】

Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia

机译:Colistin Plus万古霉素和利福平对Colistin抗性的临床和体外疗效,抗牙蛋白抗性肺炎,导致呼吸机相关的肺炎

获取原文
获取原文并翻译 | 示例
           

摘要

We present the case of a patient with ventilator-associated pneumonia (VAP) caused by a pan-resistant Acinetobacter baumannii successfully treated with the combination colistin plus vancomycin plus rifampin, whose in vitro activity was investigated by checkerboard method and killing testing. Furthermore, the serum bactericidal activity (SBA) was assessed.
机译:我们介绍了由抗损伤的肺杆菌(VAP)引起的患者患者的患者成功地用组合的Colistin Plus vancomycin Plus利福平,其体外活性通过棋盘方法和杀死测试进行了研究。 此外,评估血清杀菌活性(SBA)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号